The Joint Corp (JYNT) fair value: what the stock is really worth
As of Nov 16, 2026: fair value (intrinsic value) of The Joint Corp stock $2.23, price $6.66, that is 66.5% below the price, quality 66 out of 100. Rating: strongly overvalued. Calculated from audited financials with 20 of our 26 valuation models and 37 quality factors, updated daily.
- Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with one Yes, for free
The Joint Corp
JYNT · USFar too expensive (fair value 67% below the price) and falling price, but solid company: meets 1 of 3 rules.
What runs behind every stock
69 individual criteria per stock, every one traceable See the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year. As of Nov 14, 2026.
How to read this chart
60‑month range $6.65 – $107.30 · fair‑value band $1.89 – $2.55 · the $6.66 price screens above the $2.23 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). 1 fiscal year is left out: there the valuation rested on only a fraction of the usual models. As of Nov 14, 2026.
Every Wednesday you see whether The Joint is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Company profile
The Joint Corp. operates and is a franchisor and operator of chiropractic clinics in the United States. The company provides services under the franchise agreement, including training of franchisees and staff, site selection, construction/vendor management and ongoing operations support.
Show moreShow less
It operates through a network of franchised clinics, offering routine and affordable chiropractic adjustments using a private pay, non-insurance, cash-based model. The company was incorporated in 2010 and is headquartered in Scottsdale, Arizona.
Stock analysis
The Joint Corp (JYNT) currently trades at $6.66, while our model-based Fair Value estimate is $2.23, 67% below the price, so the stock looks overvalued today.
Show more
Valuation
Bull case: the Growth Earnings group reads highest at a median of $5.15 per share, and 1 of the 20 models we run sit above the $6.66 price.
Bear case: the Asset-Based group reads lowest at $0.4400, and 19 of the 20 models stay below the price. Data coverage for this calculation is medium.
Scenario range: $1.89 (bear) to $2.55 (bull), the price of $6.66 sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 66/100 (solid quality), in the Healthcare sector.
Weak Growth: Revenue growth is inconsistent: the periods point in different directions, so there is no trend to rely on.
The Joint Corp reported revenue of $54.9M in FY2025 versus $80.0M in FY2021, a compound −9.0%/yr. Reported net income was $2.9M in FY2025, compounding −21.3%/yr from FY2021.
Key figures
Market cap $94.9M Micro · P/E ratio 30.3 · P/S ratio 1.62 · EPS (TTM) $0.2200 · Net margin 6.5% · Return on equity 10.6% · Return on assets (EBIT) 0.9% (5-year average) · Operating margin 3.3%.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 45 out of 100 (medium confidence).
What moves the price
The share trades about 37% below its 52-week high and at its 52-week low, currently below its 200-day average.
For context, the median of 10 Healthcare peers we cover trades at −4% fair-value upside, at −67%, JYNT screens richer than that median.
Fair Value models
All 20 models by family
Quality Score breakdown
It rates the business: profits, how they develop, real cash, balance sheet, investing and share count.
Insider trades
In the last 6 months, no officer or director bought or sold shares on the open market.
- BuyCharles E Jobson10% owner13× since Nov 21, 2025: 467,408 shares, avg. $7.63$3.6MNov 10, 2026
Plus 6 other filings such as grants, option exercises or tax withholding. They are not market purchases or sales.
Sales are often planned (taxes, diversification, 10b5-1 plans). Purchases with their own money are seen as the stronger sign. For information only: not part of the quality score or Fair Value.
Source: SEC Form 4, as of Nov 16, 2026. All filings at the SEC ↗
Revenue & earnings trend
Growth Forecast
JYNT screens overvalued: fair value 67% below the price. Compare with HCA Healthcare, Inc →
Compare The Joint Corp with another stock
Price, fair value, quality and upside side by side.
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Medical Care Facilities · 248 stocks
Valuation Multiplesvs Medical Care Facilities median · lower = cheaper
Strength profile in five axes (Snowflake)
VALUE 0: the price sits above our fair-value range.
Context: sector, industry, market
- Is the Health Care sector expensive or cheap?
- P/E, EV/EBITDA and margins by industry (reference tables)
- EV/EBITDA by industry
- Dividend yield by industry
- PEG screener for stocks with fair value
- Undervalued stocks: US Stocks
- Valuation of the USA market
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
Similar stocks
10 more Medical Care Facilities stocks, each showing price versus our Fair Value estimate.
| Stock | Price | Fair Value | vs Fair Value | Compare |
|---|---|---|---|---|
| Fresenius Medical Care AG FMS | $21.86 | $45.73 | +109% | vs JYNT |
| DaVita Inc DVA | $174.22 | $218.90 | +26% | vs JYNT |
| Aier Eye Hospital Group 300015 | ¥8.99 | ¥10.88 | +21% | vs JYNT |
| HCA Healthcare, Inc HCA | $511.78 | $547.34 | +7% | vs JYNT |
| Tenet Healthcare Corporation THC | $291.54 | $279.20 | −4% | vs JYNT |
| The Ensign Group ENSG | $188.23 | $140.09 | −26% | vs JYNT |
| Encompass Health Corporation EHC | $142.11 | $94.81 | −33% | vs JYNT |
| Fresenius SE FRE | €53.86 | €34.77 | −35% | vs JYNT |
| Apollo Hospitals Enterprise Limited APOLLOHOSP | ₹8,771 | ₹5,234 | −40% | vs JYNT |
| Dr. Sulaiman Al Habib Medical Services Group 4013 | 211.40 SAR | 109.45 SAR | −48% | vs JYNT |
Explore undervalued stocks
More undervalued Healthcare stocks →
Try a ready-made strategy
Pick a strategy and jump into the live analysis with that exact screen applied.
Discover tools
Frequently asked questions
Is The Joint Corp (JYNT) overvalued or undervalued?
What is the fair value of JYNT?
What is the quality score of JYNT?
What is the price target for The Joint Corp (JYNT)?
What is the The Joint Corp stock forecast for 2026?
What is the revenue of The Joint Corp (JYNT)?
What growth is priced into The Joint Corp (JYNT)?
What discount rate (WACC) does the fair value of JYNT use?
What is a reverse DCF?
How much growth has The Joint Corp (JYNT) delivered so far?
How fast is the sector of The Joint Corp (JYNT) growing?
What is the free cash flow yield of The Joint Corp (JYNT)?
What is the intrinsic value of The Joint Corp (JYNT)?
Is The Joint Corp stock overvalued or undervalued in 2026?
Is fair value the same as the market price of JYNT?
How much is The Joint Corp worth?
What do the bullish and bearish scenarios say about JYNT?
What is the P/E ratio of JYNT?
What is the PEG ratio of JYNT?
How solid is the balance sheet of The Joint Corp (JYNT)?
How far is JYNT from its 52-week high?
Which stocks are comparable to The Joint Corp?
Is The Joint Corp stock attractive at the current price?
How is the fair value of JYNT calculated?
Is it still worth investing in stocks now?
What is the share price of The Joint Corp (JYNT)?
What should I pay attention to with The Joint Corp right now?
Key figures of The Joint Corp
How large is the market capitalisation of The Joint Corp (JYNT)?
What is the P/S ratio of The Joint Corp (JYNT)?
What are the earnings per share of The Joint Corp (JYNT)?
What is the net margin of The Joint Corp (JYNT)?
What is the return on equity of The Joint Corp (JYNT)?
What is the EBIT return on assets of The Joint Corp (JYNT)?
What is the operating margin of The Joint Corp (JYNT)?
How fast is revenue growing at The Joint Corp (JYNT)?
How fast are earnings growing at The Joint Corp (JYNT)?
How much net cash does The Joint Corp (JYNT) hold?
Watch The Joint Corp in the live analysis
One click puts The Joint Corp on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.
Watch for free →Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.